Symbols / VTGN Stock $0.60 -0.50% Vistagen Therapeutics, Inc.

Healthcare • Biotechnology • United States • NCM
VTGN (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Vistagen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for neuropsychiatric and neurological disorders. The company's product pipeline includes Fasedienol, an investigational pherine nasal spray that is in Phase III clinical trial for the treatment of anxiety in adults with social anxiety disorder; and Itruvone, an odorless synthetic investigational neuroactive pherine nasal spray, which is in Phase II clinical trial to treat major depressive disorder. It also develops PH80, an odorless and tasteless synthetic investigational pherine nasal spray that is in Phase II clinical trial for the treatment of vasomotor symptoms, including hot flashes due to menopause, premenstrual dysphoric disorder, and other women's health disorders; PH15, an investigational pherine nasal spray, which is in Phase II clinical trial for the treatment to improve cognitive impairment caused by mental fatigue and potentially other disorders; PH284, an odorless and tasteless synthetic investigational pherine nasal spray that is in Phase II clinical trial to treat loss of appetite associated with chronic disorders, such as cancer or heart disease, as well as cachexia; and AV-101, an oral prodrug that targets N-methyl-D-aspartate receptor in the brain for treating depression and neurological disorders. In addition, the company's clinical-stage pipeline consists of intranasal product candidates comprising pherines. It has a license and collaboration agreement with AffaMed Therapeutics, Inc. to develop, manufacture, and commercialize fasedienol for multiple anxiety-related disorders. Vistagen Therapeutics, Inc. was founded in 1998 and is headquartered in South San Francisco, California.

Stock Fundamentals
Scroll to Statements
Market Cap 23.87M Enterprise Value -36.48M Income -67.05M Sales 789.00K Book/sh 1.28 Cash/sh 1.56
Dividend Yield — Payout 0.00% Employees 59 IPO — P/E — Forward P/E -0.53
PEG — P/S 30.25 P/B 0.47 P/C — EV/EBITDA 0.52 EV/Sales -46.23
Quick Ratio 4.57 Current Ratio 4.67 Debt/Eq 2.80 LT Debt/Eq — EPS (ttm) -1.90 EPS next Y -1.13
EPS Growth — Revenue Growth 29.50% Earnings 2026-02-12 ROA -55.53% ROE -101.55% ROIC —
Gross Margin 100.00% Oper. Margin -64.51% Profit Margin 0.00% Shs Outstand 39.62M Shs Float 33.78M Short Float 5.08%
Short Ratio 3.02 Short Interest — 52W High 5.14 52W Low 0.43 Beta 0.33 Avg Volume 856.11K
Volume 7.59M Target Price $0.97 Recom None Prev Close $0.61 Price $0.60 Change -0.50%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$0.97
Mean price target
2. Current target
$0.60
Latest analyst target
3. DCF / Fair value
$-16.43
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.60
Low
$0.90
High
$1.00
Mean
$0.97

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-12-17 down William Blair Outperform → Market Perform —
2025-12-17 down Maxim Group Buy → Hold —
2025-12-17 down Jefferies Buy → Hold $1
2023-12-07 up Jefferies Hold → Buy $15
2023-11-14 init Stifel — → Buy $12
2023-09-05 main Maxim Group Buy → Buy $30
2023-08-07 up Maxim Group Hold → Buy $30
News
RSS: Latest VTGN news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-12-31 PRINCE JOSHUA S Chief Operating Officer — 4,386 $0.56 $2,468
2025-06-30 ADLER REID G. Officer — 7,541 $1.70 $12,820
2025-06-30 ANDERSON CYNTHIA LYNN Chief Financial Officer — 6,617 $1.70 $11,249
2025-06-30 PRINCE JOSHUA S Chief Operating Officer — 4,882 $1.70 $8,299
2025-06-30 SINGH SHAWN K Chief Executive Officer — 7,541 $1.70 $12,820
2024-12-31 ANDERSON CYNTHIA LYNN Chief Financial Officer — 2,592 $2.51 $6,499
2024-12-31 PRINCE JOSHUA S Chief Operating Officer — 3,310 $2.51 $8,300
2024-06-28 ADLER REID G. General Counsel — 4,854 $2.96 $14,358
2024-06-28 ANDERSON CYNTHIA LYNN Chief Financial Officer — 3,592 $2.96 $10,625
2024-06-28 PRINCE JOSHUA S Chief Operating Officer — 2,671 $2.96 $7,901
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total Revenue
0.49
-54.32%
1.06
+568.72%
-0.23
-120.47%
1.11
Operating Revenue
0.49
-54.32%
1.06
+568.72%
-0.23
-120.47%
1.11
Operating Expense
56.46
+65.64%
34.09
-42.27%
59.04
+21.34%
48.66
Research And Development
39.38
+96.66%
20.02
-54.88%
44.38
+25.33%
35.41
Selling General And Administration
17.08
+21.48%
14.06
-4.10%
14.66
+10.69%
13.25
Selling And Marketing Expense
—
—
1.90
-31.90%
2.80
General And Administrative Expense
17.08
+21.48%
14.06
-4.10%
14.66
+40.30%
10.45
Salaries And Wages
—
—
6.29
+2.95%
6.11
Other Gand A
17.08
+21.48%
14.06
-4.10%
14.66
+332.31%
3.39
Total Expenses
56.46
+65.64%
34.09
-42.27%
59.04
+21.34%
48.66
Operating Income
-55.97
-69.51%
-33.02
+44.29%
-59.27
-24.65%
-47.55
Total Operating Income As Reported
-55.97
-69.51%
-33.02
+44.29%
-59.27
-24.05%
-47.78
EBITDA
-55.34
-70.52%
-32.45
+44.75%
-58.74
-24.84%
-47.05
Normalized EBITDA
-55.34
-70.52%
-32.45
+44.75%
-58.74
-25.46%
-46.82
Reconciled Depreciation
0.64
+11.80%
0.57
+6.77%
0.53
-25.19%
0.71
EBIT
-55.97
-69.51%
-33.02
+44.29%
-59.27
-24.10%
-47.76
Total Unusual Items
—
—
0.00
+100.00%
-0.23
Total Unusual Items Excluding Goodwill
—
—
0.00
+100.00%
-0.23
Special Income Charges
—
—
0.00
+100.00%
-0.23
Write Off
—
—
0.00
-100.00%
0.23
Net Income
-51.42
-75.12%
-29.36
+50.44%
-59.25
-24.05%
-47.76
Pretax Income
-51.41
-75.12%
-29.36
+50.44%
-59.24
-24.04%
-47.76
Net Non Operating Interest Income Expense
4.56
+35.99%
3.35
+12788.46%
0.03
+30.00%
0.02
Interest Expense Non Operating
—
—
0.02
0.00
Net Interest Income
4.56
+35.99%
3.35
+12788.46%
0.03
+30.00%
0.02
Interest Expense
—
—
0.02
0.00
Interest Income Non Operating
4.56
+35.99%
3.35
+6738.78%
0.05
+145.00%
0.02
Interest Income
4.56
+35.99%
3.35
+6738.78%
0.05
+145.00%
0.02
Other Income Expense
0.01
-98.40%
0.31
—
-0.23
Other Non Operating Income Expenses
0.01
-98.40%
0.31
—
—
Tax Provision
0.01
+75.00%
0.00
-33.33%
0.01
+76.47%
0.00
Tax Rate For Calcs
0.00
0.00
0.00
-100.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
+100.00%
-0.00
Net Income Including Noncontrolling Interests
-51.42
-75.12%
-29.36
+50.44%
-59.25
-24.05%
-47.76
Net Income From Continuing Operation Net Minority Interest
-51.42
-75.12%
-29.36
+50.44%
-59.25
-24.05%
-47.76
Net Income From Continuing And Discontinued Operation
-51.42
-75.12%
-29.36
+50.44%
-59.25
-24.05%
-47.76
Net Income Continuous Operations
-51.42
-75.12%
-29.36
+50.44%
-59.25
-24.05%
-47.76
Normalized Income
-51.42
-75.12%
-29.36
+50.44%
-59.25
-24.65%
-47.53
Net Income Common Stockholders
-51.42
-75.12%
-29.36
+50.44%
-59.25
-21.64%
-48.71
Diluted EPS
-1.67
-9.87%
-1.52
+82.14%
-8.51
-15.31%
-7.38
Basic EPS
-1.67
-9.87%
-1.52
+82.14%
-8.51
-15.31%
-7.38
Basic Average Shares
30.88
+59.53%
19.35
+178.10%
6.96
+5.45%
6.60
Diluted Average Shares
30.88
+59.53%
19.35
+178.10%
6.96
+5.45%
6.60
Diluted NI Availto Com Stockholders
-51.42
-75.12%
-29.36
+50.44%
-59.25
-21.64%
-48.71
Insurance And Claims
—
—
1.38
+138.58%
0.58
Preferred Stock Dividends
—
—
—
0.95
Rent And Landing Fees
—
—
0.42
+11.14%
0.38
Rent Expense Supplemental
—
—
0.42
+11.14%
0.38
Total Other Finance Cost
—
-3.35
-12788.46%
-0.03
—
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total Assets
84.34
-31.79%
123.65
+486.34%
21.09
-71.75%
74.64
Current Assets
82.08
-31.98%
120.67
+589.28%
17.51
-75.34%
71.00
Cash Cash Equivalents And Short Term Investments
80.48
-32.46%
119.17
+616.23%
16.64
-75.58%
68.14
Cash And Cash Equivalents
67.13
-43.67%
119.17
+616.23%
16.64
-75.58%
68.14
Other Short Term Investments
13.35
0.00
—
—
Receivables
—
—
0.80
-70.77%
2.75
Other Receivables
—
—
0.80
-70.77%
2.75
Prepaid Assets
—
—
—
2.34
Current Deferred Assets
—
0.07
+10.45%
0.07
-42.69%
0.12
Other Current Assets
1.59
+5.84%
1.51
+87.78%
0.80
+1016.99%
0.07
Total Non Current Assets
2.27
-24.02%
2.98
-16.78%
3.58
-1.74%
3.65
Net PPE
1.81
-19.69%
2.25
-18.50%
2.77
-10.05%
3.08
Gross PPE
3.21
-8.38%
3.51
-11.39%
3.96
-8.86%
4.35
Accumulated Depreciation
-1.40
-11.96%
-1.25
-5.11%
-1.19
+5.97%
-1.27
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.11
+413.64%
0.02
-45.00%
0.04
-47.51%
0.08
Other Properties
2.88
-11.98%
3.27
-11.68%
3.71
-8.60%
4.05
Leases
0.22
+3.27%
0.21
+0.00%
0.21
-0.19%
0.21
Non Current Deferred Assets
—
0.62
-12.46%
0.71
+52.50%
0.47
Non Current Prepaid Assets
—
0.10
+0.00%
0.10
+0.10%
0.10
Other Non Current Assets
0.45
-37.47%
0.73
—
—
Total Liabilities Net Minority Interest
13.95
+48.94%
9.37
+3.97%
9.01
-9.26%
9.93
Current Liabilities
12.61
+146.18%
5.12
+12.00%
4.57
-20.66%
5.77
Payables And Accrued Expenses
6.10
+182.15%
2.16
-26.23%
2.93
-27.09%
4.02
Payables
0.65
-57.79%
1.55
-37.44%
2.47
-10.35%
2.76
Accounts Payable
0.65
-57.79%
1.55
-37.44%
2.47
-10.35%
2.76
Current Accrued Expenses
5.45
+784.74%
0.62
+34.20%
0.46
-63.66%
1.26
Pensionand Other Post Retirement Benefit Plans Current
3.36
+107.54%
1.62
+380.42%
0.34
+409.06%
0.07
Current Debt And Capital Lease Obligation
0.56
+2.00%
0.55
-6.94%
0.59
+36.40%
0.43
Current Debt
—
—
0.10
—
Current Capital Lease Obligation
0.56
+2.00%
0.55
+13.17%
0.49
+12.16%
0.43
Current Deferred Liabilities
2.59
+227.18%
0.79
+10.78%
0.71
-42.60%
1.24
Current Deferred Revenue
2.59
+227.18%
0.79
+10.78%
0.71
-42.60%
1.24
Total Non Current Liabilities Net Minority Interest
1.34
-68.45%
4.24
-4.31%
4.43
+6.53%
4.16
Long Term Debt And Capital Lease Obligation
0.95
-39.62%
1.57
-25.94%
2.12
-18.63%
2.61
Long Term Capital Lease Obligation
0.95
-39.62%
1.57
-25.94%
2.12
-18.63%
2.61
Tradeand Other Payables Non Current
—
—
—
0.00
Non Current Deferred Liabilities
0.39
-85.38%
2.67
+15.51%
2.31
+48.63%
1.56
Non Current Deferred Revenue
0.39
-85.38%
2.67
+15.51%
2.31
+48.63%
1.56
Stockholders Equity
70.39
-38.41%
114.29
+846.08%
12.08
-81.33%
64.72
Common Stock Equity
70.39
-38.41%
114.29
+846.08%
12.08
-81.33%
64.72
Capital Stock
0.03
+7.41%
0.03
+285.71%
0.01
+1.45%
0.01
Common Stock
0.03
+7.41%
0.03
+285.71%
0.01
+1.45%
0.01
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
29.00
+7.29%
27.03
+269.49%
7.32
+6.19%
6.89
Ordinary Shares Number
29.00
+7.30%
27.03
+269.66%
7.31
+6.19%
6.88
Treasury Shares Number
0.00
+0.00%
0.00
+0.02%
0.00
-0.02%
0.00
Additional Paid In Capital
481.96
+1.58%
474.44
+38.36%
342.89
+1.97%
336.28
Retained Earnings
-407.63
-14.43%
-356.21
-8.98%
-326.85
-22.14%
-267.60
Gains Losses Not Affecting Retained Earnings
0.01
0.00
—
—
Treasury Stock
3.97
+0.00%
3.97
+0.00%
3.97
0.00%
3.97
Other Equity Adjustments
0.01
—
—
—
Total Equity Gross Minority Interest
70.39
-38.41%
114.29
+846.08%
12.08
-81.33%
64.72
Total Capitalization
70.39
-38.41%
114.29
+846.08%
12.08
-81.33%
64.72
Working Capital
69.46
-39.88%
115.55
+793.44%
12.93
-80.17%
65.23
Invested Capital
70.39
-38.41%
114.29
+837.92%
12.19
-81.17%
64.72
Total Debt
1.51
-28.82%
2.12
-21.80%
2.71
-10.78%
3.04
Capital Lease Obligations
1.51
-28.82%
2.12
-18.65%
2.61
-14.24%
3.04
Net Tangible Assets
70.39
-38.41%
114.29
+846.08%
12.08
-81.33%
64.72
Tangible Book Value
70.39
-38.41%
114.29
+846.08%
12.08
-81.33%
64.72
Current Notes Payable
—
0.00
-100.00%
0.10
0.00
Line Item Trend 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Operating Cash Flow
-42.10
-63.08%
-25.81
+48.08%
-49.72
-9.85%
-45.26
Cash Flow From Continuing Operating Activities
-42.10
-63.08%
-25.81
+48.08%
-49.72
-9.85%
-45.26
Net Income From Continuing Operations
-51.42
-75.12%
-29.36
+50.44%
-59.25
-24.05%
-47.76
Depreciation Amortization Depletion
0.64
+11.80%
0.57
+6.77%
0.53
-25.19%
0.71
Depreciation
0.64
+11.80%
0.57
+6.77%
0.53
-25.19%
0.71
Depreciation And Amortization
0.64
+11.80%
0.57
+6.77%
0.53
-25.19%
0.71
Other Non Cash Items
—
—
3.56
—
Stock Based Compensation
4.32
+97.75%
2.18
-34.59%
3.34
-4.16%
3.48
Asset Impairment Charge
—
—
0.00
-100.00%
0.23
Operating Gains Losses
—
0.01
-92.31%
0.08
—
Gain Loss On Investment Securities
—
—
0.08
—
Gain Loss On Sale Of PPE
0.00
-100.00%
0.01
0.00
—
Change In Working Capital
4.76
+500.25%
0.79
-60.88%
2.03
+205.69%
-1.92
Change In Prepaid Assets
-0.09
-135.20%
0.25
-92.16%
3.19
+265.77%
-1.92
Change In Payables And Accrued Expense
5.68
+988.31%
0.52
+155.89%
-0.93
-155.37%
1.69
Change In Other Working Capital
-0.22
-143.02%
0.52
+150.49%
0.21
+120.51%
-1.00
Change In Other Current Liabilities
-0.61
-23.43%
-0.49
-14.32%
-0.43
+36.04%
-0.68
Investing Cash Flow
-13.15
-21454.10%
-0.06
+91.76%
-0.74
-269.26%
-0.20
Cash Flow From Continuing Investing Activities
-13.15
-21454.10%
-0.06
+91.76%
-0.74
-269.26%
-0.20
Net PPE Purchase And Sale
-0.19
-213.11%
-0.06
+71.23%
-0.21
-5.79%
-0.20
Purchase Of PPE
-0.19
-213.11%
-0.06
+71.23%
-0.21
-5.79%
-0.20
Capital Expenditure
-0.19
-213.11%
-0.06
+71.23%
-0.21
-5.79%
-0.20
Net Investment Purchase And Sale
-12.96
0.00
—
—
Purchase Of Investment
-24.98
0.00
—
—
Sale Of Investment
12.03
0.00
—
—
Net Business Purchase And Sale
—
0.00
+100.00%
-0.53
0.00
Purchase Of Business
—
0.00
+100.00%
-0.53
0.00
Financing Cash Flow
3.21
-97.50%
128.40
+12434.49%
-1.04
-109.93%
10.48
Cash Flow From Continuing Financing Activities
3.21
-97.50%
128.40
+12434.49%
-1.04
-109.93%
10.48
Net Issuance Payments Of Debt
0.00
+100.00%
-0.98
+4.74%
-1.03
-34366.67%
-0.00
Issuance Of Debt
—
—
—
0.00
Repayment Of Debt
0.00
+100.00%
-0.98
+4.74%
-1.03
-34366.67%
-0.00
Long Term Debt Issuance
—
—
—
0.00
Long Term Debt Payments
—
—
-0.00
+50.00%
-0.00
Net Long Term Debt Issuance
—
—
-0.00
+50.00%
-0.00
Short Term Debt Payments
0.00
+100.00%
-0.98
+4.74%
-1.03
0.00
Net Short Term Debt Issuance
0.00
+100.00%
-0.98
+4.74%
-1.03
0.00
Net Common Stock Issuance
3.01
-97.67%
129.38
+184927.14%
-0.07
-101.58%
4.44
Common Stock Payments
—
—
-0.17
—
Repurchase Of Capital Stock
—
—
-0.17
—
Proceeds From Stock Option Exercised
0.20
+2412.50%
0.01
-87.30%
0.06
-98.96%
6.05
Changes In Cash
-52.03
-150.75%
102.53
+299.10%
-51.50
-47.25%
-34.97
Beginning Cash Position
119.17
+616.23%
16.64
-75.58%
68.14
-33.92%
103.11
End Cash Position
67.13
-43.67%
119.17
+616.23%
16.64
-75.58%
68.14
Free Cash Flow
-42.29
-63.44%
-25.87
+48.18%
-49.93
-9.84%
-45.46
Interest Paid Supplemental Data
—
—
—
0.00
Income Tax Paid Supplemental Data
—
—
—
0.00
Amortization Of Securities
-0.39
0.00
—
—
Common Stock Issuance
3.01
-97.67%
129.38
+124302.88%
0.10
-97.66%
4.44
Issuance Of Capital Stock
3.01
-97.67%
129.38
+124302.88%
0.10
-97.66%
4.44
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category